Prostate Cancer and PI-RADS 3 Changes
Author Information
Author(s): Muacevic Alexander, Adler John R, Sofi Junaid, Subedi Pradip, Pradhan Ameena
Primary Institution: Northwick Park Hospital - London North West University Healthcare NHS Trust
Hypothesis
Do diffuse, bilateral PI-RADS 3 changes on MRI indicate clinically significant prostate cancer?
Conclusion
Clinically significant prostate cancer is likely in diffuse PI-RADS 3 changes, especially with high PSA density.
Supporting Evidence
- 30.5% of men with bilateral diffuse PI-RADS 3 changes were diagnosed with clinically significant prostate cancer.
- The study found a significant correlation between PSA density and cancer diagnosis in these changes.
- The study emphasizes caution before deciding against biopsying these changes.
Takeaway
This study found that many men with certain MRI changes might actually have prostate cancer, so doctors should be careful before deciding not to do a biopsy.
Methodology
Data from 108 men with diffuse, bilateral PI-RADS 3 changes on MRI who underwent systematic prostate biopsy were analyzed.
Potential Biases
The study focused only on a specific subset of PI-RADS 3 changes, which may introduce bias.
Limitations
The study's retrospective design and small sample size may limit the generalizability of the findings.
Participant Demographics
Mean age was 61.15 years, with a range of 41-78 years; included various ethnicities.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website